BUSINESS NETWORKING FORUM United States AND GERMANY
Your opportunity to cooperate with German companies in the healthcare and medical biotechnology sectors
A delegation of innovative German companies from the healthcare industry and medical biotechnology sectors will travel to the United States on behalf of the Federal Ministry for Economic Affairs and Energy (BMWE). The participating German companies represent a broad spectrum of expertise, including solutions and technologies in medical biotechnology, life sciences, pharmaceuticals, diagnostics, digital health, medical technology, and healthcare innovation.
The aim of the mission is to foster direct business contacts, exchange know-how, and explore new opportunities for German-American cooperation.
Organized By trAIDe GmbH (Germany) & TAVA Land & Expand (USA)
All information at a glance
Business Networking Forum - Muscat
Boston, USA
Tuesday Oct/06/2026
B2B Meetings
Location: Holiday Inn Cambridge Boston
9:00 am –01:00 pm | B2B Meeting Session
Business Networking Forum - Muscat
San Diego (La Jolla), USA
Thursday, Oct/08/2026
B2B Meetings & Business Lunch
Location: Hyatt La Jolla
09:00-09:30 am | Registration
9:30–12:00 pm | Industry Forum
12:00–01:00 pm | Networking Lunch
01:00–05:00 pm | B2B Meetings
Official German Civil Security and Defence Industry
Supported by the Federal Ministry for Economic Affairs and Energy (BMWE) as part of the “Mittelstand Global” (Global SMEs) initiative
Business Networking Forum
India - Bangalore
Date: Tuesday, 07th of July
Location: Vivanta Hotel Residency Road
xxx | Bangalore | India
India - Pune
Date: Wedsenday, 08th of July
Location: Sheraton Grand Pune Bund Garden Hotel
xxx | Pune | India
Registration
Click here to register directly for the B2B Networking Forum
9:30 - 10:00 | Registrations
10:00 - 12:00 | Industry Presentations & Keynote Speeches
12:00 - 13:00 | Networking Lunch
13:00 - 18:00 | B2B Meetings
The Project
trAIDe GmbH has been commissioned to carry out this project as part of the federal funding program Mittelstand Global/Foreign Market Entry Programme. The Foreign Market Entry Programme for small and medium-sized enterprises is a funding program of the Federal Ministry for Economic Affairs and Energy.
On behalf of
On behalf of
This business initiation trip to the United States focuses on the healthcare industry and medical biotechnology sectors and is therefore supported by the export initiative HEALTH MADE IN GERMANY. The HEALTH MADE IN GERMANY initiative is implemented by Germany Trade & Invest on behalf of the Federal Ministry for Economic Affairs and Energy. The export initiative for the German healthcare industry bundles expert market intelligence for easy industry access.
Areas covered by the export initiative:
- Pharmaceuticals
- Medical technology
- Medical biotechnology
- Digital healthcare services
- Healthcare products and services made in Germany
German Delegation
Participating German Companies
company
MAE Maschinen- und Apparatebau Götzen GmbH
MAE Maschinen- und Apparatebau Götzen GmbH (MAE Group) is a German manufacturer of high-precision straightening machines and customized production systems, with a focus on applications in the medical device and life science sectors. The company develops tailored solutions for small-diameter, high-precision components such as surgical drills, dental instruments, and other critical parts requiring exceptional straightness and consistency.
company
Injecta GmbH
Injecta GmbH is a German manufacturer specializing in stainless steel precision tubing and cannula solutions for medical and industrial applications. With more than 100 years of manufacturing expertise and as part of the globally active Sarstedt Group, the company combines deep production know-how with modern, high-quality manufacturing standards. Injecta operates its own advanced production facilities and delivers fully integrated, high-precision tubular components to customers worldwide.
company
ions.bio GmbH
ions.bio GmbH is a Germany-based biotechnology company providing end-to-end proteomics solutions for drug discovery, biomarker development, and translational research. The company integrates biosample sourcing, high-throughput mass spectrometry, and advanced bioinformatics into a unified platform that transforms biological questions into actionable insights. With extensive scientific expertise and a strong track record in large-scale data generation, ions.bio serves biotech, pharma, AI, and academic partners globally.
company
Green Elephant Biotech
Green Elephant Biotech is an innovation-driven biotechnology company focused on advancing manufacturing technologies for adherent cell-based therapies. The company develops scalable and automated solutions that enable more efficient production of Cell & Gene Therapies, vaccines, and biologics. With a strong focus on process efficiency and industrial scalability, Green Elephant Biotech addresses key bottlenecks in modern therapeutic manufacturing.
company
HEADS UP! GmbH
HEADS UP! GmbH is a specialized German Clinical Research Organization (CRO) focused on Health Analytics and Data Science. Founded in 2024, the company supports pharmaceutical, biotechnology and medical device organizations with clinical trial planning, biostatistics, statistical programming, clinical data management, HEOR, medical writing and AI-driven analytics solutions. The team consists of experienced data scientists, statisticians, natural scientists and health analytics professionals delivering high-quality, regulatory-compliant data services to global healthcare clients. .
company
Allogenetics
Allogenetics’ mission is to enable longer and healthier lives for transplant patients by fine-tuning the balance between immune tolerance and protection. The company is advancing an ex vivo gene therapy designed as a one-time treatment to modify the donor organ. Allogenetics’ goal is to eliminate the need for lifelong immunosuppression and its challenges to improve graft survival and patient quality of life. Building on compelling proof-of-concept in animal models, the company will bring its novel organ-agnostic approach into human clinical trials, starting with lung grafts. By leveraging our immune-tolerance approach Allogenetics is building a new path toward addressing life-threatening conditions and the global organ shortage crisis.
company
KNAUER Wissenschaftliche Geräte GmbH
KNAUER Wissenschaftliche Geräte GmbH is a German family-owned manufacturer of high-performance laboratory instrumentation, specializing in liquid chromatography systems, osmometers, and advanced technologies for lipid nanoparticle (LNP) formulation and oligonucleotide production. Founded in 1962 and headquartered in Berlin, the company serves the pharmaceutical, biotechnology, research, food, and environmental sectors with premium-quality, German-engineered solutions. The company already has an established customer base in the United States and further strengthened its presence through the launch of KNAUER Life Science Inc. in Cambridge, Massachusetts, providing local sales and service support.
company
Sci2Sci
Sci2Sci is a Germany-based enterprise software company (founded in 2024) specializing in data governance and data intelligence solutions for the biopharma and life sciences industry. The company focuses on enabling large organizations to organize, structure, and operationalize complex and fragmented data environments to support AI-driven research and decision-making. With initial traction in international pharma companies and a focus on enterprise data teams, Sci2Sci aims to become a foundational data infrastructure provider for highly regulated industries.
company
Kimetec GmbH
Kimetec GmbH is a German manufacturer of innovative medical devices, specializing in hygiene, diagnostic, and nursing solutions. The company has a presence in the US and develops patented, sustainable technologies designed to improve patient care, enhance healthcare efficiency, and support infection prevention across a wide range of clinical settings. With a strong focus on innovation, quality, and practical healthcare applications, Kimetec serves customers in hospitals, care facilities, and medical practices worldwide.
company
LIQOMICS GmbH
LIQOMICS GmbH is a Cologne-based diagnostics company founded in 2021, operating at the intersection of oncology, genomics, and clinical diagnostics. The company combines medical expertise and bioinformatics to provide advanced cancer monitoring services based on blood samples. It follows a service-driven business model, working with hospitals, oncologists, laboratories, and research partners on a national and international level. Built on translational research from the University of Cologne, LIQOMICS has established itself as a specialized player in the emerging field of liquid biopsy diagnostics.
company
Benkana Interfaces
Benkana Interfaces is a specialized consultancy with extensive experience in Human Factors Engineering, usability, and regulatory support for manufacturers of medical devices, IVDR products, and Software as a Medical Device. At the forefront of current regulatory changes, the company supports manufacturers in shifting from traditional, resource –intensive FDA approvals toward rapid, agile modification pathways under the PCCP framework. Their services cover the full product development cycle, from user research and fully managed usability testing to audit-ready documentation for the worldwide market access (US, Europe, China, …). Benkana Interfaces also provides integrated services for requirements engineering, risk management, and design control.
company
CheckImmune GmbH
CheckImmune GmbH is a Berlin-based innovative biomarker service company and a spin-off from Charité-Universitätsmedizin Berlin, specializing in immunology-driven analyses for clinical development. The company provides end-to-end biomarker solutions, including consulting, laboratory services, and scientific data interpretation to support drug development and clinical trials. With a strong focus on immunotherapeutics, CheckImmune leverages advanced technologies such as flow cytometry, proteomics, and single-cell multiomics to deliver high-quality, GCLP-compliant data.
